Upload
karen-charles
View
37
Download
0
Embed Size (px)
Citation preview
GENTOX
MEDICAL SERVICES
Start with These People:
• PHARMACOGENETICS (DNA) TESTING: o ALL Medicare/Geriatric Patients. Especially Multi-Pharmacy Patients. o Anyone you feel are not getting the full results of drug regiments like you
thought they should. o Anyone experiencing Adverse Reactions, Side Effects or Allergic Reactions. o Anyone Taking Major Medications during Pregnancy. o Anyone that is Nervous about taking medications.
• URIN/SALIVA DRUG TESTING (UDT), TOXICOLOGY: o All Patients taking any kind of Pain or Psychotropic Medication. o Patients experiencing uncomfortable side effects to their medications. o High Risk Patients should be 2-4 times a month, Moderate Risk Patients 2-4
times a quarter, Low Risk 2-4 times a year.
• HEREDITARY CANCER TESTING: o ALL Patients with any kind of Cancer or rare Disease History within their
immediate family.
• ALLERGY: o ALL Patients experiencing airborne allergies. o ALL Patients who are on constant allergy medications and experience continual
congestion.
• HPV TEST AND/OR PAP SMEARS: o All women over the age of 25. o CT/NG TESTING (Chlamydia/Gonorrhea). o VAGINOSIS PANEL (Cadida, Gardnerella, Trichomonas).
• WHOLE GENOME CHROMOSOMAL MICROARRAY ANALYSIS o Unexplained developmental delay/intellectual disability. o Autism or Autism Spectrum Disorder. o Developmental or Learning Problems, or Growth Abnormalities. o Dysmorphic Features, Birth Defects, or Multiple Congenital Anomalies. o Seizure Disorder or Hypotonia. o Uniparental Disomy or conditions resulting from shared Parental Ancestry
(Consanguinity).
FRAGILE X DNA ANALYSIS
o Unexplained developmental delay/intellectual disability. o Autism or Autism Spectrum Disorder. o Developmental or Learning Problems, or Growth Abnormalities. o Cytogenetic findings consistent with FXS. o Adult-onset Tremor/Ataxia. o Female infertility associated with elevated follicle-stimulated (FSH) or Primary
Ovarian Insufficiency. • CYSTIC FIBROSIS CF-139 PANEL:
o Carrier o All women of child-bearing age regardless of race or ethnicity. o Individuals or Couples with a positive family history of CF.
o Diagnostic o Suspected or known diagnosis of CF. o Congenital absence of the Vas Deferens (CAVD, males).
• C-VRAS – CARDIO-VASCULAR RISK ASSESSMENT o ALL WOMEN that had any level of Preeclampsia during pregnancy.
• PATERNITY TESTING o Court Admissible Test. o Personal Use Screen.
• OARS ASSESMENT TOOL o ALL patients at the onset of using the tool. o All New patients.